SMILES

The main scientific objective of SMILES is to identify, characterise and exploit the antimicrobial peptides (AMPs) produced by Streptococcus dentisani and select cocktails with biomedical applications in the treatment of caries and periodontitis. S. dentisani is a probiotic bacterium that produces AMPs and is found naturally in individuals free of oral diseases, maintaining the balance for a healthy oral microbiota. Caries and periodontitis are two oral diseases derived from microbial dysbiosis. These cocktails could be incorporated in the future as additives in conventional oral hygiene products (e.g., toothpastes) as preventive agents for oral diseases accessible to the public regardless of their financial resources. This action will train and prepare Dr Revilla-Guarinos to set up her own group in academia or, alternatively, to develop a new career in industry, working at the forefront of applied microbiology in Europe.

Funding agency

European Comission

Programme

Horizon 2020-MSCA 

Full name

Streptococcus dentisani's Antimicrobial Peptides: New Strategy Against Oral Diseases of Microbial Origin 

Reference

101026278 

Acronym

SMILES 

Involvement

Coordinator 

Principal investigator

Ainhoa Revilla Guarinos 

Scientific supervisor

Alejandro Mira Obrador 

Period

2022-2026 

Budget

160.932,48€ 

Web

https://cordis.europa.eu/project/id/101026278